Key points from article :
Scientists at École Polytechnique Fédérale de Lausanne created supercharged immune cells (CAR T cells) for cancer treatment.
They engineered these cells to make their own medicine, a molecule called interleukin-10 (IL-10), to keep fighting even in the harsh environment around tumors.
This new immunotherapy completely eliminated cancer in mice, including melanoma, colon, breast, and pancreatic cancers.
It even prevented new tumors from forming when cancer cells were reintroduced.
Early human trials show promising results. All 11 patients achieved complete remission so far, with the potential for faster and cheaper treatment compared to existing options.
It has the potential to improve the effectiveness and accessibility of this treatment for many cancer patients.
The study was published in Nature Biotechnology, highlighting the significance and potential of this new immunotherapy technique.
